Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Group",
"id" : "179507",
"meta" : {
"versionId" : "4",
"lastUpdated" : "2023-12-04T16:37:09.673Z",
"profile" : [
🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/cohort-definition"
]
},
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Group</b><a name=\"179507\"> </a><a name=\"hc179507\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceGroup "179507" Version "4" Updated "2023-12-04 16:37:09+0000" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-cohort-definition.html\">CohortDefinition</a></p></div><p><b>Artifact related artifact</b>: </p><p><b>Artifact Title</b>: CohortDefinition: Proxy criteria for surgical candidates</p><p><b>Artifact URL</b>: <a href=\"https://fevir.net/resources/Group/179507\">https://fevir.net/resources/Group/179507</a></p><p><b>Artifact Publisher</b>: Computable Publishing LLC</p><p><b>Artifact Copyright</b>: https://creativecommons.org/licenses/by-nc-sa/4.0/</p><p><b>Artifact use context</b>: <span title=\"{https://fevir.net/resources/CodeSystem/179423 evidence-communication}\">Evidence Communication</span>: <span title=\"Codes: {https://fevir.net/resources/CodeSystem/179423 CohortDefinition}\">CohortDefinition</span></p><p><b>Artifact Contact</b>: <a href=\"mailto:support@computablepublishing.com\">support@computablepublishing.com</a></p><p><b>Artifact Author</b>: Brian S. Alper: </p><p><b>CombinationMethod</b>: all-of</p><blockquote><p><b>modifierExtension[http://hl7.org/fhir/StructureDefinition/artifact-status]</b></p></blockquote><p><b>identifier</b>: FEvIR Object Identifier/179507</p><p><b>type</b>: animal</p><p><b>membership</b>: definitional</p><p><b>name</b>: CohortDefinition_Proxy_criteria_for_surgical_candidates</p><p><b>description</b>: Exclusion Criteria: Cardiovascular event (myocardial infarction, acute coronary syndrome, coronary artery angioplasty or bypass, stroke) in the past six months. Current evidence of congestive heart failure, angina pectoris, or symptomatic peripheral vascular disease. Cardiac stress test indicating that surgery or IMM would not be safe. Pulmonary embolus or thrombophlebitis in the past six months. Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years. Significant anemia (hemoglobin 1.0 g or more below normal range) or history of coagulopathy. Serum creatinine ≥ 1.5 mg/dl. HbA1c > 14.0%.</p><blockquote><p><b>characteristic</b></p><p><b>CharacteristicDescription</b>: Cardiovascular event (myocardial infarction, acute coronary syndrome, coronary artery angioplasty or bypass, stroke) in the past six months.</p><blockquote><p><b>CharacteristicTiming</b></p><blockquote><p><b>url</b></p><code>contextCode</code></blockquote><p><b>value</b>: Assessment of eligibility for clinical trial (procedure) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOWMED CT</a>#450332002)</span></p><blockquote><p><b>url</b></p><code>offset</code></blockquote><p><b>value</b>: -6-0 months</p><blockquote><p><b>url</b></p><code>text</code></blockquote><p><b>value</b>: occurrence within the range is equivalent to 'in the past six months'</p></blockquote><p><b>code</b>: Defined by Reference <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ()</span></p><p><b>value</b>: <a href=\"Group-170442.html\">Group/170442: CohortDefinition: Cardiovascular event</a> "CohortDefinition_Cardiovascular_event"</p><p><b>exclude</b>: true</p></blockquote><blockquote><p><b>characteristic</b></p><p><b>CharacteristicDescription</b>: Pulmonary embolus in the past six months.</p><blockquote><p><b>CharacteristicTiming</b></p><blockquote><p><b>url</b></p><code>contextCode</code></blockquote><p><b>value</b>: Assessment of eligibility for clinical trial (procedure) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOWMED CT</a>#450332002)</span></p><blockquote><p><b>url</b></p><code>offset</code></blockquote><p><b>value</b>: -6-0 months</p><blockquote><p><b>url</b></p><code>text</code></blockquote><p><b>value</b>: in the past six months</p></blockquote><p><b>code</b>: Disease (disorder) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOWMED CT</a>#64572001; <a href=\"http://hl7.org/fhir/R5/codesystem-fhir-types.html\">All FHIR Types</a>#Condition "Condition")</span></p><p><b>value</b>: Pulmonary embolism (disorder) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOWMED CT</a>#59282003)</span></p><p><b>exclude</b>: true</p></blockquote><blockquote><p><b>characteristic</b></p><p><b>CharacteristicDescription</b>: Thrombophlebitis in the past six months.</p><blockquote><p><b>CharacteristicTiming</b></p><blockquote><p><b>url</b></p><code>contextCode</code></blockquote><p><b>value</b>: Assessment of eligibility for clinical trial (procedure) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOWMED CT</a>#450332002)</span></p><blockquote><p><b>url</b></p><code>offset</code></blockquote><p><b>value</b>: -6-0 months</p><blockquote><p><b>url</b></p><code>text</code></blockquote><p><b>value</b>: in the past six months</p></blockquote><p><b>code</b>: Disease (disorder) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOWMED CT</a>#64572001; <a href=\"http://hl7.org/fhir/R5/codesystem-fhir-types.html\">All FHIR Types</a>#Condition "Condition")</span></p><p><b>value</b>: Thrombophlebitis (disorder) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOWMED CT</a>#64156001)</span></p><p><b>exclude</b>: true</p></blockquote><blockquote><p><b>characteristic</b></p><p><b>CharacteristicDescription</b>: Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years.</p><p><b>code</b>: Defined by Reference <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ()</span></p><p><b>value</b>: <a href=\"Group-170441.html\">Group/170441: CohortDefinition: Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years</a> "CohortDefinition_Cancer_of_any_kind_except_basal_cell_skin_cancer_or_cancer_in_situ_unless_documented_to_be_disease_free_for_five_years"</p><p><b>exclude</b>: true</p></blockquote><blockquote><p><b>characteristic</b></p><p><b>CharacteristicDescription</b>: Significant anemia (hemoglobin 1.0 g or more below normal range)</p><p><b>CharacteristicOffset</b>: Lower Normal Limit <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-characteristic-offset.html\">Characteristic Offset</a>#LNL)</span></p><p><b>code</b>: Hemoglobin [Mass/volume] in Blood <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#718-7)</span></p><p><b>value</b>: <=-1 g/dL<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code g/dL = 'g/dL')</span></p><p><b>exclude</b>: true</p></blockquote><blockquote><p><b>characteristic</b></p><p><b>CharacteristicDescription</b>: Serum creatinine ≥ 1.5 mg/dl</p><p><b>code</b>: Creatinine [Mass/volume] in Serum or Plasma <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#2160-0)</span></p><p><b>value</b>: >=1.5 mg/dl<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg/dL = 'mg/dL')</span></p><p><b>exclude</b>: true</p></blockquote><blockquote><p><b>characteristic</b></p><p><b>CharacteristicDescription</b>: HbA1c ≥ 14.0%</p><p><b>code</b>: Hemoglobin A1c/Hemoglobin.total in Blood by IFCC protocol <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#59261-8)</span></p><p><b>value</b>: >=14 %<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code % = '%')</span></p><p><b>exclude</b>: true</p></blockquote></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact",
"valueRelatedArtifact" : {
"type" : "cite-as",
"citation" : "CohortDefinition: Proxy criteria for surgical candidates [Group]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179507. Revised 2023-11-24. Available at: https://fevir.net/resources/Group/179507. Computable resource at: https://fevir.net/resources/Group/179507."
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-title",
"valueString" : "CohortDefinition: Proxy criteria for surgical candidates"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-url",
"valueUri" : "https://fevir.net/resources/Group/179507"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-publisher",
"valueString" : "Computable Publishing LLC"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-copyright",
"valueMarkdown" : "https://creativecommons.org/licenses/by-nc-sa/4.0/"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-useContext",
"valueUsageContext" : {
"code" : {
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "evidence-communication",
"display" : "Evidence Communication"
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "CohortDefinition",
"display" : "CohortDefinition"
}
]
}
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-contact",
"valueContactDetail" : {
"telecom" : [
{
"system" : "email",
"value" : "support@computablepublishing.com"
}
]
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-author",
"valueContactDetail" : {
"name" : "Brian S. Alper"
}
},
{
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/combination-method",
"valueCode" : "all-of"
}
],
"modifierExtension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-status",
"valueCode" : "active"
}
],
"identifier" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "ACSN",
"display" : "Accession ID"
}
],
"text" : "FEvIR Object Identifier"
},
"system" : "https://fevir.net",
"value" : "179507",
"assigner" : {
"display" : "Computable Publishing LLC"
}
}
],
"type" : "animal",
"membership" : "definitional",
"name" : "CohortDefinition_Proxy_criteria_for_surgical_candidates",
"description" : "Exclusion Criteria: Cardiovascular event (myocardial infarction, acute coronary syndrome, coronary artery angioplasty or bypass, stroke) in the past six months. Current evidence of congestive heart failure, angina pectoris, or symptomatic peripheral vascular disease. Cardiac stress test indicating that surgery or IMM would not be safe. Pulmonary embolus or thrombophlebitis in the past six months. Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years. Significant anemia (hemoglobin 1.0 g or more below normal range) or history of coagulopathy. Serum creatinine ≥ 1.5 mg/dl. HbA1c > 14.0%.",
"characteristic" : [
{
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description",
"valueMarkdown" : "Cardiovascular event (myocardial infarction, acute coronary syndrome, coronary artery angioplasty or bypass, stroke) in the past six months."
},
{
"extension" : [
{
"url" : "contextCode",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "450332002",
"display" : "Assessment of eligibility for clinical trial (procedure)"
}
]
}
},
{
"url" : "offset",
"valueRange" : {
"low" : {
"value" : -6,
"unit" : "months",
"system" : "http://unitsofmeasure.org",
"code" : "mo"
},
"high" : {
"value" : 0,
"unit" : "months",
"system" : "http://unitsofmeasure.org",
"code" : "mo"
}
}
},
{
"url" : "text",
"valueString" : "occurrence within the range is equivalent to 'in the past six months'"
}
],
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-timing"
}
],
"code" : {
"text" : "Defined by Reference"
},
"valueReference" : {
🔗 "reference" : "Group/170442",
"type" : "Group",
"display" : "CohortDefinition: Cardiovascular event"
},
"exclude" : true
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description",
"valueMarkdown" : "Pulmonary embolus in the past six months."
},
{
"extension" : [
{
"url" : "contextCode",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "450332002",
"display" : "Assessment of eligibility for clinical trial (procedure)"
}
]
}
},
{
"url" : "offset",
"valueRange" : {
"low" : {
"value" : -6,
"unit" : "months",
"system" : "http://unitsofmeasure.org",
"code" : "mo"
},
"high" : {
"value" : 0,
"unit" : "months",
"system" : "http://unitsofmeasure.org",
"code" : "mo"
}
}
},
{
"url" : "text",
"valueString" : "in the past six months"
}
],
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-timing"
}
],
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "64572001",
"display" : "Disease (disorder)"
},
{
"system" : "http://hl7.org/fhir/fhir-types",
"code" : "Condition",
"display" : "Condition"
}
]
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "59282003",
"display" : "Pulmonary embolism (disorder)"
}
]
},
"exclude" : true
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description",
"valueMarkdown" : "Thrombophlebitis in the past six months."
},
{
"extension" : [
{
"url" : "contextCode",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "450332002",
"display" : "Assessment of eligibility for clinical trial (procedure)"
}
]
}
},
{
"url" : "offset",
"valueRange" : {
"low" : {
"value" : -6,
"unit" : "months",
"system" : "http://unitsofmeasure.org",
"code" : "mo"
},
"high" : {
"value" : 0,
"unit" : "months",
"system" : "http://unitsofmeasure.org",
"code" : "mo"
}
}
},
{
"url" : "text",
"valueString" : "in the past six months"
}
],
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-timing"
}
],
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "64572001",
"display" : "Disease (disorder)"
},
{
"system" : "http://hl7.org/fhir/fhir-types",
"code" : "Condition",
"display" : "Condition"
}
]
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "64156001",
"display" : "Thrombophlebitis (disorder)"
}
]
},
"exclude" : true
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description",
"valueMarkdown" : "Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years."
}
],
"code" : {
"text" : "Defined by Reference"
},
"valueReference" : {
🔗 "reference" : "Group/170441",
"type" : "Group",
"display" : "CohortDefinition: Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years"
},
"exclude" : true
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description",
"valueMarkdown" : "Significant anemia (hemoglobin 1.0 g or more below normal range)"
},
{
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-offset",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/characteristic-offset",
"code" : "LNL",
"display" : "Lower Normal Limit"
}
]
}
}
],
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "718-7",
"display" : "Hemoglobin [Mass/volume] in Blood"
}
]
},
"valueQuantity" : {
"value" : -1,
"comparator" : "<=",
"unit" : "g/dL",
"system" : "http://unitsofmeasure.org",
"code" : "g/dL"
},
"exclude" : true
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description",
"valueMarkdown" : "Serum creatinine ≥ 1.5 mg/dl"
}
],
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "2160-0",
"display" : "Creatinine [Mass/volume] in Serum or Plasma"
}
]
},
"valueQuantity" : {
"value" : 1.5,
"comparator" : ">=",
"unit" : "mg/dl",
"system" : "http://unitsofmeasure.org",
"code" : "mg/dL"
},
"exclude" : true
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description",
"valueMarkdown" : "HbA1c ≥ 14.0%"
}
],
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "59261-8",
"display" : "Hemoglobin A1c/Hemoglobin.total in Blood by IFCC protocol"
}
]
},
"valueQuantity" : {
"value" : 14,
"comparator" : ">=",
"unit" : "%",
"system" : "http://unitsofmeasure.org",
"code" : "%"
},
"exclude" : true
}
]
}
IG © 2022+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#1.0.0-ballot based on FHIR 5.0.0. Generated 2024-05-17
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change